Matches in SemOpenAlex for { <https://semopenalex.org/work/W2729651908> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2729651908 endingPage "11582" @default.
- W2729651908 startingPage "11582" @default.
- W2729651908 abstract "11582 Background: The onset and maintenance of cancer frequently involves gain of oncogenic function along with loss of tumor suppression. PTEN is a well-characterized tumor suppressor gene that is lost or mutated in many human cancers including ~50% of metastatic castration-resistant prostate cancer (mCRPC). Reintroduction of functional PTEN for mCRPC treatment has proven difficult. Methods: PTEN mRNA was synthesized by in vitro transcription method and modified with ARCA capping and enzymatic polyadenylation, and then substituted with Pseudo-UTP, 5’-Methyl-CTP. A robust self-assembly approach was employed to prepare PTEN mRNA nanoparticles (NPs) using cationic lipid-like compound G0-C14 and PLGA polymer coated with lipid-PEG shell. PTEN expression in tumors and PI3K-AKT pathway were confirmed by IHC and western blot, respectively. Apoptosis was checked by flow cytometry and Tunel assays. In vivo toxicity was studied by hematologic and histologic tests, and immune response. Results: We successfully restored PTEN mRNA to PTEN-null prostate cancer (PCa) cells via systemic delivery of mRNA NPs. These mRNA NPs are stable in serum, demonstrate minimal toxicity, and provide highly effective transfection in PCa cells (substantially higher HA-PTEN expression than plasmid PTEN transfection) and PCa xenograft tumors, leading to ~85% inhibition of tumor cell growth in vitro and in vivo. We also confirm mRNA NP-mediated systemic restoration of PTEN function in PTEN-null PCa and delineate its tumor suppression through inhibition of the PI3K-AKT pathway and enhancement of apoptosis. Conclusions: The work provides proof of principle for the systemic reintroduction of mRNA-based tumor suppressor genes to tumors in vivo. Because PTEN loss is frequent in late-stage PCa, this approach may have feasibility in this patient population. Considering the strong potential of mRNA therapy and the lack of systemic studies of in vivo mRNA transfection of tumors, this study sheds light on the useful application of NP-mediated mRNA delivery for validating tumor suppressors (e.g., PTEN) as a therapeutic target in cancer treatment where loss of a tumor suppressor contributes to the underlying genetic mechanism of cancer." @default.
- W2729651908 created "2017-07-14" @default.
- W2729651908 creator A5010758104 @default.
- W2729651908 creator A5020016130 @default.
- W2729651908 creator A5021544404 @default.
- W2729651908 creator A5032324140 @default.
- W2729651908 creator A5042597057 @default.
- W2729651908 creator A5046999994 @default.
- W2729651908 creator A5053752264 @default.
- W2729651908 creator A5056766924 @default.
- W2729651908 creator A5057745939 @default.
- W2729651908 creator A5081564266 @default.
- W2729651908 date "2017-05-20" @default.
- W2729651908 modified "2023-09-25" @default.
- W2729651908 title "Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles." @default.
- W2729651908 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.11582" @default.
- W2729651908 hasPublicationYear "2017" @default.
- W2729651908 type Work @default.
- W2729651908 sameAs 2729651908 @default.
- W2729651908 citedByCount "2" @default.
- W2729651908 countsByYear W27296519082018 @default.
- W2729651908 countsByYear W27296519082022 @default.
- W2729651908 crossrefType "journal-article" @default.
- W2729651908 hasAuthorship W2729651908A5010758104 @default.
- W2729651908 hasAuthorship W2729651908A5020016130 @default.
- W2729651908 hasAuthorship W2729651908A5021544404 @default.
- W2729651908 hasAuthorship W2729651908A5032324140 @default.
- W2729651908 hasAuthorship W2729651908A5042597057 @default.
- W2729651908 hasAuthorship W2729651908A5046999994 @default.
- W2729651908 hasAuthorship W2729651908A5053752264 @default.
- W2729651908 hasAuthorship W2729651908A5056766924 @default.
- W2729651908 hasAuthorship W2729651908A5057745939 @default.
- W2729651908 hasAuthorship W2729651908A5081564266 @default.
- W2729651908 hasConcept C121608353 @default.
- W2729651908 hasConcept C126322002 @default.
- W2729651908 hasConcept C150903083 @default.
- W2729651908 hasConcept C153911025 @default.
- W2729651908 hasConcept C190283241 @default.
- W2729651908 hasConcept C207001950 @default.
- W2729651908 hasConcept C2777609662 @default.
- W2729651908 hasConcept C2780192828 @default.
- W2729651908 hasConcept C502942594 @default.
- W2729651908 hasConcept C55493867 @default.
- W2729651908 hasConcept C71924100 @default.
- W2729651908 hasConcept C75217442 @default.
- W2729651908 hasConcept C86554907 @default.
- W2729651908 hasConcept C86803240 @default.
- W2729651908 hasConceptScore W2729651908C121608353 @default.
- W2729651908 hasConceptScore W2729651908C126322002 @default.
- W2729651908 hasConceptScore W2729651908C150903083 @default.
- W2729651908 hasConceptScore W2729651908C153911025 @default.
- W2729651908 hasConceptScore W2729651908C190283241 @default.
- W2729651908 hasConceptScore W2729651908C207001950 @default.
- W2729651908 hasConceptScore W2729651908C2777609662 @default.
- W2729651908 hasConceptScore W2729651908C2780192828 @default.
- W2729651908 hasConceptScore W2729651908C502942594 @default.
- W2729651908 hasConceptScore W2729651908C55493867 @default.
- W2729651908 hasConceptScore W2729651908C71924100 @default.
- W2729651908 hasConceptScore W2729651908C75217442 @default.
- W2729651908 hasConceptScore W2729651908C86554907 @default.
- W2729651908 hasConceptScore W2729651908C86803240 @default.
- W2729651908 hasIssue "15_suppl" @default.
- W2729651908 hasLocation W27296519081 @default.
- W2729651908 hasOpenAccess W2729651908 @default.
- W2729651908 hasPrimaryLocation W27296519081 @default.
- W2729651908 hasRelatedWork W1606861223 @default.
- W2729651908 hasRelatedWork W1993312761 @default.
- W2729651908 hasRelatedWork W2219191688 @default.
- W2729651908 hasRelatedWork W2319211179 @default.
- W2729651908 hasRelatedWork W2511723070 @default.
- W2729651908 hasRelatedWork W2744966301 @default.
- W2729651908 hasRelatedWork W2986129865 @default.
- W2729651908 hasRelatedWork W3032600770 @default.
- W2729651908 hasRelatedWork W3132820354 @default.
- W2729651908 hasRelatedWork W3192317526 @default.
- W2729651908 hasVolume "35" @default.
- W2729651908 isParatext "false" @default.
- W2729651908 isRetracted "false" @default.
- W2729651908 magId "2729651908" @default.
- W2729651908 workType "article" @default.